INmune Bio Inc Cash Flow Quality Index
Latest as of December 2025:
-0.07x
INmune Bio Inc cash flow quality index. INmune Bio Inc (INMB) has a Cash Flow Quality Index of -0.07x as of December 2025. Operating cash flow of $-2.96 Million is below net income of $40.75 Million, suggesting accrual-heavy earnings not yet converted to cash. See INmune Bio Inc (INMB) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-0.07x
Operating CF / Net Income
Operating Cash Flow
$-2.96 Million
USD
Net Income
$40.75 Million
USD
Data as of
Dec 2025
Most recent filing
INmune Bio Inc Cash Flow Quality Index by Year (None–None)
INmune Bio Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for INmune Bio Inc. For the full cash flow conversion analysis, see INmune Bio Inc (INMB) cash conversion ratio.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.